JPRN-UMIN000042091
Not Yet Recruiting
N/A
Prospective intervention study aimed at establishing a circumference measurement method for lower limb lymphedema. - Study of lower limb lymphedema.
Hamamatsu University School of Medicine Hospital rehabilitation department0 sites80 target enrollmentOctober 19, 2020
Conditionsower limb edema.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ower limb edema.
- Sponsor
- Hamamatsu University School of Medicine Hospital rehabilitation department
- Enrollment
- 80
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with deep vein thrombosis Patients with serious heart disease Persons with serious liver disease (or persons with AST 100U/L or less) Persons with severe renal disease (or serum creatinine 1\.3mg/dl or higher) Women who are pregnant or may become pregnant Patients with a pacemaker Patients with venous disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
tility of Homoeopathy in MigraineHealth Condition 1: G431- Migraine with auraHealth Condition 2: G430- Migraine without auraHealth Condition 3: G439- Migraine, unspecifiedCTRI/2024/05/067106Rajkot Homoeopathic Medical College
Recruiting
N/A
Study to create a library of signals generated by asthmatic and non-asthmatic subjects through a smartphone-based App to estimate lung healthHealth Condition 1: J459- Other and unspecified asthmaCTRI/2024/05/067343Cipla Ltd
Not Yet Recruiting
N/A
To study the effectiveness of individualized homoeopathic medicine in cases of sciatica.CTRI/2024/05/067967Sainath Hospital
Active, Not Recruiting
Phase 4
Study to Determine the Effectiveness of ORSL�® variants as an Adjuvant to help restore Oral Fluid, Electrolytes and Energy (FEE) Along With Standard of Care Medication Treatment inRecovery for Subjects With Fever And/Or General Weakness in Out-Patient Setting Among the Indian PopulatioCTRI/2021/10/037363Johnson and Johnson Pte Limited
Recruiting
N/A
Prospective interventional clinical study to evaluate the efficacy and safety of atezolizumab plus bevacizumab in combination with carbon ion radiotherapy for unresectable hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000051549Yamagata University20